Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | APAF1 | O14727 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16107838 | 0.89 | MEN1 (0.43) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL1736186 | 0.89 | FDPS (0.35) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL357140 | 0.87 | MEN1 (0.51) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Trifluoromethanesulfonic Acid SCHEMBL133213 | 0.86 | FDPS (0.40) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Sulfuric Acid SCHEMBL5527767 | 0.85 | FDPS (0.42) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL1735067 | 0.84 | MEN1 (0.59) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL1736115 | 0.84 | MEN1 (0.59) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL1735957 | 0.84 | MEN1 (0.59) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL1736110 | 0.84 | MEN1 (0.59) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL1858368 | 0.84 | MEN1 (0.59) | FDPSSMN1; SMN2MEN1APAF1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3470493-B1 | COMPOSITIONS COMPRISING LATENT HEAT STORAGE MATERIALS | PHASE CHANGE ENERGY SOLUTIONS INC (US) | 2024-05-15 | — | — | EP | claimed |
| WO-2024081696-A2 | COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| US-11567385-B2 | Electrochromic device | THE BOEING COMPANY (US) | 2023-01-31 | — | — | US | claimed |
| EP-3753973-B1 | A METHOD FOR SEALING A GAP BETWEEN ADJOINING OR CONNECTED SOLID SURFACES ON AN AIRCRAFT | BOEING CO (US) | 2022-09-28 | — | — | EP | claimed |
| CN-115010836-A | Electrochromatic polymer, nano particles and device | 吉林大学 | 2022-09-06 | — | — | CN | claimed |
| US-20220171247-A1 | ELECTROCHROMIC DEVICE | THE BOEING COMPANY | 2022-06-02 | — | — | US | claimed |
| CN-109280186-B | Method and composition for curing the surface of uncured polysulfide rubber | 波音公司 | 2022-05-10 | — | — | CN | claimed |
| US-11307476-B2 | Electrochromic device | THE BOEING COMPANY (US) | 2022-04-19 | — | — | US | claimed |
| US-11292853-B2 | Methods and compositions for curing a surface of an uncured polysulfide rubber | THE BOEING COMPANY (US) | 2022-04-05 | — | — | US | claimed |
| CN-109504015-B | Electrochromic polymer material based on combination strategy and preparation of electrochromic device | 常州铱视光电科技有限公司 | 2021-05-11 | — | — | CN | claimed |
| US-20100174120-A1 | PROCESSES FOR MAKING DIBUTYL ETHERS FROM ISOBUTANOL | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-08 | — | — | US | claimed |
| US-7544813-B2 | Ionic liquids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-06-09 | — | — | US | claimed |
| EP-1940914-B1 | PREPARATION OF POLYTRIMETHYLENE ETHER GLYCOL AND COPOLYMERS THEREOF | DU PONT (US) | 2009-05-13 | — | — | EP | claimed |
| US-7528287-B2 | Preparation of poly(tetramethylene) glycol | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-05-05 | — | — | US | claimed |
| US-7238772-B2 | Preparation of polytrimethylene ether glycol and copolymers thereof | E. I. DU PONT DE NEMOURS AND COMPANY (DE) | 2007-07-03 | — | — | US | claimed |
| US-20070100181-A1 | Olefin isomerization | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-03 | — | — | US | claimed |
| US-20070100184-A1 | Alkylation of aromatic compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-03 | — | — | US | claimed |
| US-20070066854-A1 | Preparation of polytrimethylene ether glycol and copolymers thereof | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | claimed |
| US-20070066852-A1 | Preparation of poly(tetramethylene) glycol | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | claimed |
| US-20070066822-A1 | Ionic liquids | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174120-A1 | PROCESSES FOR MAKING DIBUTYL ETHERS FROM ISOBUTANOL | EBP, PPIP5K2, PCBP1 | FDPS 334/4885SMN1; SMN2 3499/4885MEN1 3323/4885 |
| US-20070100184-A1 | Alkylation of aromatic compounds | TYR, ALK, AHR | FDPS 793/4885SMN1; SMN2 4678/4885MEN1 1923/4885 |
| US-20070066854-A1 | Preparation of polytrimethylene ether glycol and copolymers thereof | PARG, PTGES3, PGD | FDPS 1220/4885SMN1; SMN2 3739/4885MEN1 1773/4885 |
| US-20070100181-A1 | Olefin isomerization | OSBP, OXER1, ALOX12 | FDPS 853/4885SMN1; SMN2 3162/4885MEN1 3487/4885 |
| US-20070066822-A1 | Ionic liquids | AFF2, AFF1, ZYX | FDPS 2830/4885SMN1; SMN2 1091/4885MEN1 1207/4885 |
| US-20070066852-A1 | Preparation of poly(tetramethylene) glycol | PARG, PUF60, TPR | FDPS 551/4885SMN1; SMN2 710/4885MEN1 322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.